Learning Objectives:

1.  Why is the FDA now interested in measuring PROs?

2.  Identify 3 problems with existing health-related quality of life PROs for type 1 diabetes.

3.  List 2 common themes of health-related quality of life across different stages of development.


Session date: 
03/11/2019 - 5:00pm to 6:00pm CDT
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Barbara J. Anderson, Ph.D.